GENENTECH, INC for GENENTECH INC

Pharmacy PHA

Issues relating to drug pricing Education on policies pertaining to the 340B Drug Discount Program

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; Treasury, Dept of

Medical/Disease Research/Clinical Labs MED

Issues related to Right to Try

Contacted: White House Office; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of; SENATE

Trade (domestic/foreign) TRD

Trade Policy Issues. Trade Negotiations.

Contacted: Treasury, Dept of; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; White House Office; SENATE; Centers For Medicare and Medicaid Services (CMS)

Taxation/Internal Revenue Code TAX

General tax issues. Issues related to corporate tax reform

Contacted: HOUSE OF REPRESENTATIVES; Treasury, Dept of; White House Office; Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS)

Copyright/Patent/Trademark CPT

Intellectual property and process patent issues. General IP issues. Patent litigation reform.

Contacted: White House Office; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Treasury, Dept of

Health Issues HCR

H.R. 1628 American Health Care Act of 2017; Better Care Reconciliation Act; General education, guidance and strategic counsel about policies impacting pharmaceutical development, approval and reimbursement; H.R. 2430/S. 934, FDA Reauthorization Act of 2017 General education about FDA approval policies including pediatric trial design, and right-to-try proposals Advocated to include market incentives for antimicrobials in H.R. 2430 / S. 934 - FDA Reauthorization Act of 2017 Implementation issues related to the Pharmaceutical Quality, Security and Accountability Act (P.L. 113-54) Issues related to drug pricing Education around issues relating to the 340B Drug Discount Program Issues related to FDA and HHS program funding in the FY18 Labor, Health and Human Services, and Education and Related Agencies, and FY18 Agriculture, Rural Developments, Food and Drug Administrations, and Related Agencies Appropriation bills

Contacted: White House Office; Treasury, Dept of; SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: S. 934 (115th), H.R. 1628 (115th), H.R. 2430 (115th)

Medicare/Medicaid MMM

Education around issues relating to the 340B Drug Discount Program General education around policies related to Medicare Part B coverage and reimbursement CHIP Reauthorization Policies on drug reimportation Policies around drug pricing Medicare payment for inpatient antimicrobials

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE; Treasury, Dept of; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Budget/Appropriations BUD

FY2018, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations FY 2018, Consolidation Appropriations Act of 2017 (P.L. 115-31)

Contacted: Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; White House Office